A new study from Zurich and Leipzig reveals why some obese people remain healthy while others develop metabolic diseases. The research highlights key differences in fat type, cell behaviour, and ...

A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial ...

High ultraprocessed food (UPF) consumption during early childhood is associated with obesity development, primarily in males, ...

Body weight and body mass index alone are not enough to predict whether someone will develop a metabolic disease. A new atlas of cells in fat tissue could help to explain why some overweight people ...

As BMI is increasingly recognized as an imperfect way to measure health, UVA researchers share other metrics they rely upon.

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

As many as 40% of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers, according to the CDC. New research from the ...

Neurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably have the same ...

Novo expects to continue to grow its reach in 2025, though perhaps not at the magnitude witnessed in 2024. For the full year to come, Novo Nordisk is eyeing sales growth at constant currencies between ...

Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people ...

The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...